治験から臨床現場への情報提供
スポンサーリンク
概要
- 論文の詳細を見る
In this report, we introduce the importance of a system for sharing information about cancer molecular-targeted medicines from trial to the clinic by the department of knowledge education research, department of breast surgical oncology, department of cardiovascular internal medicine and department of dermatology at St. Luke's International Hospital in Japan. At present, information regarding the side effect(s) of a study drug does not reach doctors who are not members of the department in charge of the clinical trial. The reason for this is because clinical trials are conducted under the legal constraints of GCP (Good clinical practice), and while safety information about any adverse events (side effects) is reported, it is limited to the level of an Institutional Review Board. When there was an enquiry about a known side effect that had occurred to patients taking molecular-target medicine from a doctor who was not a member of the department in charge of the clinical trial, it became clear that information regarding the clinical trial medicine and non-approved medicine was not reaching the clinic. We developed an original reporting system for such information that would offer the information using the same format as the clinical trial itself, as well as the department in which the side effect was treated, to resolve the problem of access to side effect information outside of the clinical trial itself. We show that the reporting of such information leads to resolution of this problem. We believe that this will relieve the patient and contribute to the clinical trial as well as to the department that deals with such side effects.
- 日本医薬品情報学会の論文
日本医薬品情報学会 | 論文
- 一般用医薬品の添付文書理解度調査法の開発:―理解度への影響因子の検討―
- 汎用データベースソフトを用いた持参薬識別システムの構築と有用性の検討
- 実務実習生の医薬品情報リテラシー向上を目的とした医薬品情報実習の効果
- 医療用および一般用医薬品を対象としたドーピング防止早見表の作成
- Preparation of Quick Reference Table on Incompatibilities of Injections for Use in the ICU and Investigation of the Usefulness of This Table